{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:15:57Z","timestamp":1790615757296,"version":"4.1.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T00:00:00Z","timestamp":1712534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T00:00:00Z","timestamp":1712534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["Vanier Canada Graduate Scholarship"],"award-info":[{"award-number":["Vanier Canada Graduate Scholarship"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009776","name":"McMaster University","doi-asserted-by":"publisher","award":["Department of Family Medicine Pilot Project Grant"],"award-info":[{"award-number":["Department of Family Medicine Pilot Project Grant"]}],"id":[{"id":"10.13039\/100009776","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007461","name":"Fondation Brocher","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007461","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs","doi-asserted-by":"publisher","award":["Ethical Complexity in Primary Care"],"award-info":[{"award-number":["Ethical Complexity in Primary Care"]}],"id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Community Genet"],"DOI":"10.1007\/s12687-024-00705-y","type":"journal-article","created":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T14:02:12Z","timestamp":1712584932000},"page":"293-309","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Patient perspectives on pharmacogenomic (PGx) testing for antidepressant prescribing in primary care: a qualitative description study"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6007-7825","authenticated-orcid":false,"given":"Alexandra","family":"Cernat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5974-9361","authenticated-orcid":false,"given":"Zainab","family":"Samaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2907-2783","authenticated-orcid":false,"given":"Julia","family":"Abelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3162-4871","authenticated-orcid":false,"given":"Amanada","family":"Ramdyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadia","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7347-6259","authenticated-orcid":false,"given":"Meredith","family":"Vanstone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,8]]},"reference":[{"key":"705_CR1","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.2147\/ndt.S312966","volume":"17","author":"S Aboelbaha","year":"2021","unstructured":"Aboelbaha S, Zolezzi M, Elewa H (2021) Effect of pharmacogenetic-based decision support tools in improving depression outcomes: A systematic review. Neuropsychiatr Dis Treat 17:2397\u20132419. https:\/\/doi.org\/10.2147\/ndt.S312966","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"8","key":"705_CR2","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1177\/0706743720904820","volume":"65","author":"A Al Maruf","year":"2020","unstructured":"Al Maruf A, Fan M, Arnold PD, Muller DJ, Aitchison KJ, Bousman CA (2020) Pharmacogenetic testing options relevant to psychiatry in Canada. Can J Psychiatry 65(8):521\u2013530. https:\/\/doi.org\/10.1177\/0706743720904820","journal-title":"Can J Psychiatry"},{"key":"705_CR3","doi-asserted-by":"publisher","unstructured":"Allen JD, Pittenger AL, Bishop JR (2022) A scoping review of attitudes and experiences with pharmacogenomic testing among patients and the general public: Implications for patient counseling. J Pers Med 12(3). https:\/\/doi.org\/10.3390\/jpm12030425","DOI":"10.3390\/jpm12030425"},{"key":"705_CR4","doi-asserted-by":"crossref","unstructured":"Bagautdinova D, Lteif C, Eddy E, Terrell J, Fisher CL, Duarte JD (2022) Patients\u2019 perspectives of factors that influence pharmacogenetic testing uptake: Enhancing patient counseling and results dissemination. Journal of Personalized Medicine 12(12): 2046. https:\/\/www.mdpi.com\/2075-4426\/12\/12\/2046","DOI":"10.3390\/jpm12122046"},{"issue":"4","key":"705_CR5","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.sapharm.2020.06.022","volume":"17","author":"D Bright","year":"2021","unstructured":"Bright D, Worley M, Porter BL (2021) Patient perceptions of pharmacogenomic testing in the community pharmacy setting. Res Social Adm Pharm 17(4):744\u2013749. https:\/\/doi.org\/10.1016\/j.sapharm.2020.06.022","journal-title":"Res Social Adm Pharm"},{"issue":"6","key":"705_CR6","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1002\/cpt.2748","volume":"112","author":"LC Brown","year":"2022","unstructured":"Brown LC, Stanton JD, Bharthi K, Maruf AA, M\u00fcller DJ, Bousman CA (2022) Pharmacogenomic testing and depressive symptom remission: A systematic review and meta-analysis of prospective. Controlled Clinical Trials Clin Pharmacol Ther 112(6):1303\u20131317. https:\/\/doi.org\/10.1002\/cpt.2748","journal-title":"Controlled Clinical Trials Clin Pharmacol Ther"},{"issue":"12","key":"705_CR7","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1177\/1049732320945303","volume":"30","author":"R Burgess","year":"2020","unstructured":"Burgess R, Cernat A, Little L, Vanstone M (2020) Implementing publicly funded noninvasive prenatal testing for fetal aneuploidy in Ontario, Canada: Clinician Experiences With a Disruptive Technology. Qual Health Res 30(12):1941\u20131952. https:\/\/doi.org\/10.1177\/1049732320945303","journal-title":"Qual Health Res"},{"key":"705_CR8","unstructured":"CADTH (2020) Pharmacogenomic testing for medication selection: A rapid qualitative review. https:\/\/www.cadth.ca\/sites\/default\/files\/rr\/2020\/RC1246%20PxGx%20Qualitative%20FINAL.pdf. Accessed Jan 2024"},{"key":"705_CR9","unstructured":"CADTH (2021) Pharmacogenomic testing in depression: a 2021 update. Available from: https:\/\/www.cadth.ca\/sites\/default\/files\/pdf\/htis\/2022\/RC1403%20RxGx%20testing%20depression%20update%20Final.pdf. Accessed Jan 2024"},{"key":"705_CR10","unstructured":"CADTH (2023) An overview of pharmacogenomic testing for psychiatric disorders. https:\/\/www.cadth.ca\/sites\/default\/files\/pdf\/htis\/2023\/EH0115%20Pharmacogenomic%20Testing%20for%20Psychiatric%20Disorders.pdf. Accessed Jan 2024"},{"key":"705_CR11","doi-asserted-by":"publisher","unstructured":"CANMAT (2016) CANMAT 2016 clinical guidelines for the management of adults with major depressive disorder. Canadian J Psych 61(9). https:\/\/doi.org\/10.1177\/0706743716660034","DOI":"10.1177\/0706743716660034"},{"key":"705_CR12","unstructured":"Clinical Pharmacogenetics Implementation Consortium (CPIC) (2023) Genes-drugs. https:\/\/cpicpgx.org\/genes-drugs\/.\u00a0Accessed 30 Mar 2024"},{"issue":"1","key":"705_CR13","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1365-2648.2007.04569.x","volume":"62","author":"S Elo","year":"2008","unstructured":"Elo S, Kyng\u00e4s H (2008) The qualitative content analysis process. J Adv Nursing 62(1):107\u2013115. https:\/\/doi.org\/10.1111\/j.1365-2648.2007.04569.x","journal-title":"J Adv Nursing"},{"key":"705_CR14","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.pnpbp.2018.05.007","volume":"86","author":"C Fabbri","year":"2018","unstructured":"Fabbri C, Zohar J, Serretti A (2018) Pharmacogenetic tests to guide drug treatment in depression: Comparison of the available testing kits and clinical trials. Prog Neuropsychopharmacol Biol Psychiatry 86:36\u201344. https:\/\/doi.org\/10.1016\/j.pnpbp.2018.05.007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"8","key":"705_CR15","doi-asserted-by":"publisher","first-page":"589","DOI":"10.2217\/pgs-2019-0004","volume":"20","author":"MP Frigon","year":"2019","unstructured":"Frigon MP, Blackburn ME, Dubois-Bouchard C, Gagnon AL, Tardif S, Tremblay K (2019) Pharmacogenetic testing in primary care practice: opinions of physicians, pharmacists and patients. Pharmacogenomics 20(8):589\u2013598. https:\/\/doi.org\/10.2217\/pgs-2019-0004","journal-title":"Pharmacogenomics"},{"key":"705_CR16","doi-asserted-by":"publisher","unstructured":"Gartlehner G, Hansen RA, Morgan LC, Thaler K, Lux L, Van Noord M, ... Lohr KN (2011) Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder. Ann Intern Med 155(11): 772\u2013785. https:\/\/doi.org\/10.7326\/0003-4819-155-11-201112060-00009","DOI":"10.7326\/0003-4819-155-11-201112060-00009"},{"key":"705_CR17","doi-asserted-by":"publisher","unstructured":"Ghanbarian S, Wong GWK, Bunka M, Edwards L, Cressman S, Conte T, ... Bryan S (2023) Cost-effectiveness of pharmacogenomic-guided treatment for major depression. Cmaj 195(44): E1499-e1508. https:\/\/doi.org\/10.1503\/cmaj.221785","DOI":"10.1503\/cmaj.221785"},{"key":"705_CR18","doi-asserted-by":"publisher","unstructured":"Greden JF, Parikh SV, Rothschild AJ, Thase ME, Dunlop BW, DeBattista C, ... Dechairo B (2019) Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, patient- and rater-blinded, randomized, controlled study. J Psychiatr Res 111:59\u201367. https:\/\/doi.org\/10.1016\/j.jpsychires.2019.01.003","DOI":"10.1016\/j.jpsychires.2019.01.003"},{"issue":"7","key":"705_CR19","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1097\/01.gim.0000227935.26763.c6","volume":"8","author":"SD Grosse","year":"2006","unstructured":"Grosse SD, Khoury MJ (2006) What is the clinical utility of genetic testing? Genet Med 8(7):448\u2013450. https:\/\/doi.org\/10.1097\/01.gim.0000227935.26763.c6","journal-title":"Genet Med"},{"key":"705_CR20","unstructured":"Hayes Inc (2016) Pharmacogenomic testing for selected conditions: a health technology assessment prepared for the Washington State Healthcare Authority. https:\/\/www.hca.wa.gov\/assets\/program\/pharmacogenomics-final-rpt-20161209.pdf. Accessed Jan 2024"},{"issue":"12","key":"705_CR21","doi-asserted-by":"publisher","first-page":"761","DOI":"10.2217\/pgs-2021-0032","volume":"22","author":"J Hayward","year":"2021","unstructured":"Hayward J, McDermott J, Qureshi N, Newman W (2021) Pharmacogenomic testing to support prescribing in primary care: a structured review of implementation models. Pharmacogenomics 22(12):761\u2013776. https:\/\/doi.org\/10.2217\/pgs-2021-0032","journal-title":"Pharmacogenomics"},{"key":"705_CR22","doi-asserted-by":"publisher","unstructured":"Hendricks-Sturrup RM, Lu CY (2019) Direct-to-consumer genetic testing data privacy: Key concerns and recommendations based on consumer perspectives. J Pers Med 9(2). https:\/\/doi.org\/10.3390\/jpm9020025","DOI":"10.3390\/jpm9020025"},{"key":"705_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2021.114523","volume":"292","author":"M Hennink","year":"2022","unstructured":"Hennink M, Kaiser BN (2022) Sample sizes for saturation in qualitative research: A systematic review of empirical tests. Soc Sci Med 292:114523. https:\/\/doi.org\/10.1016\/j.socscimed.2021.114523","journal-title":"Soc Sci Med"},{"key":"705_CR24","doi-asserted-by":"publisher","unstructured":"Herbert D, Neves-Pereira M, Baidya R, Cheema S, Groleau S, Shahmirian A, ... Kennedy JL (2018) Genetic testing as a supporting tool in prescribing psychiatric medication: Design and protocol of the IMPACT study. J Psychiatr Res 96:265\u2013272. https:\/\/doi.org\/10.1016\/j.jpsychires.2017.09.002","DOI":"10.1016\/j.jpsychires.2017.09.002"},{"issue":"5","key":"705_CR25","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1002\/cpt.1611","volume":"106","author":"RB Kim","year":"2019","unstructured":"Kim RB (2019) Precision medicine: Lessons learned from implementation of a pharmacogenetics-based patient care program in a real-world setting. Clin Pharmacol Therapeutics 106(5):933\u2013935. https:\/\/doi.org\/10.1002\/cpt.1611","journal-title":"Clin Pharmacol Therapeutics"},{"issue":"5","key":"705_CR26","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/fpc.0000000000000275","volume":"27","author":"YM Lee","year":"2017","unstructured":"Lee YM, McKillip RP, Borden BA, Klammer CE, Ratain MJ, O\u2019Donnell PH (2017) Assessment of patient perceptions of genomic testing to inform pharmacogenomic implementation. Pharmacogenet Genomics 27(5):179\u2013189. https:\/\/doi.org\/10.1097\/fpc.0000000000000275","journal-title":"Pharmacogenet Genomics"},{"key":"705_CR27","doi-asserted-by":"publisher","unstructured":"Lemke AA, Hulick PJ, Wake DT, Wang C, Sereika AW, Yu KD, ... Dunnenberger HM (2018) Patient perspectives following pharmacogenomics results disclosure in an integrated health system. Pharmacogenomics 19(4):321\u2013331. https:\/\/doi.org\/10.2217\/pgs-2017-0191","DOI":"10.2217\/pgs-2017-0191"},{"issue":"6","key":"705_CR28","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1055\/a-1183-5029","volume":"53","author":"I Liko","year":"2020","unstructured":"Liko I, Lai E, Griffin RJ, Aquilante CL, Lee YM (2020) Patients\u2019 perspectives on psychiatric pharmacogenetic testing. Pharmacopsychiatry 53(6):256\u2013261. https:\/\/doi.org\/10.1055\/a-1183-5029","journal-title":"Pharmacopsychiatry"},{"key":"705_CR29","doi-asserted-by":"publisher","unstructured":"Linde K, Kriston L, R\u00fccker G, Jamil S, Schumann I, Meissner K, ... Schneider A (2015) Efficacy and acceptability of pharmacological treatments for depressive disorders in primary care: systematic review and network meta-analysis. Ann Fam Med 13(1):69\u201379. https:\/\/doi.org\/10.1370\/afm.1687","DOI":"10.1370\/afm.1687"},{"key":"705_CR30","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/j.1749-6632.1993.tb26351.x","volume":"703","author":"J Lomas","year":"1993","unstructured":"Lomas J (1993) Diffusion, dissemination, and implementation: who should do what? Ann N Y Acad Sci 703:226\u2013235. https:\/\/doi.org\/10.1111\/j.1749-6632.1993.tb26351.x. (discussion 235\u2013227)","journal-title":"Ann N Y Acad Sci"},{"key":"705_CR31","doi-asserted-by":"publisher","unstructured":"Madadi P, Joly Y, Avard D, Chitayat DC, Smith MA, Ross CJD, ... Koren G (2010) Communicating pharmacogenetic research results to breastfeeding mothers taking codeine: A pilot study of perceptions and benefits. Clin Pharmacol Therapeutics 88(6):792\u2013795. https:\/\/doi.org\/10.1038\/clpt.2010.125","DOI":"10.1038\/clpt.2010.125"},{"issue":"9","key":"705_CR32","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1176\/ps.2009.60.9.1167","volume":"60","author":"TL Mark","year":"2009","unstructured":"Mark TL, Levit KR, Buck JA (2009) Datapoints: Psychotropic drug prescriptions by medical specialty. Psychiatr Serv 60(9):1167\u20131167. https:\/\/doi.org\/10.1176\/ps.2009.60.9.1167","journal-title":"Psychiatr Serv"},{"issue":"6","key":"705_CR33","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1002\/cpt.2122","volume":"109","author":"G McInnes","year":"2021","unstructured":"McInnes G, Lavertu A, Sangkuhl K, Klein TE, Whirl-Carrillo M, Altman RB (2021) Pharmacogenetics at scale: An analysis of the UK Biobank. Clin Pharmacol Therapeutics 109(6):1528\u20131537. https:\/\/doi.org\/10.1002\/cpt.2122","journal-title":"Clin Pharmacol Therapeutics"},{"issue":"9","key":"705_CR34","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/nrg1428","volume":"5","author":"UA Meyer","year":"2004","unstructured":"Meyer UA (2004) Pharmacogenetics \u2013 five decades of therapeutic lessons from genetic diversity. Nat Rev Genet 5(9):669\u2013676. https:\/\/doi.org\/10.1038\/nrg1428","journal-title":"Nat Rev Genet"},{"issue":"7","key":"705_CR35","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1001\/jama.1957.72980250010016","volume":"165","author":"AG Motulsky","year":"1957","unstructured":"Motulsky AG (1957) Drug reactions, enzymes, and biochemical genetics. J Am Med Assoc 165(7):835\u2013837. https:\/\/doi.org\/10.1001\/jama.1957.72980250010016","journal-title":"J Am Med Assoc"},{"issue":"1","key":"705_CR36","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41525-018-0065-4","volume":"3","author":"G Mukerjee","year":"2018","unstructured":"Mukerjee G, Huston A, Kabakchiev B, Piquette-Miller M, van Schaik R, Dorfman R (2018) User considerations in assessing pharmacogenomic tests and their clinical support tools. Genomic Med 3(1):26. https:\/\/doi.org\/10.1038\/s41525-018-0065-4","journal-title":"Genomic Med"},{"key":"705_CR37","unstructured":"NICE (2022) NICE health technology evaluations: the manual. https:\/\/www.nice.org.uk\/process\/pmg36\/chapter\/introduction-to-health-technology-evaluation. Accessed Jan 2024"},{"key":"705_CR38","doi-asserted-by":"crossref","unstructured":"O\u2019Brien BC, Harris IB, Beckman TJ, Reed DA, Cook DA (2014) Standards for reporting qualitative research: a synthesis of recommendations. Academic Medicine 89(9). https:\/\/journals.lww.com\/academicmedicine\/Fulltext\/2014\/09000\/Standards_for_Reporting_Qualitative_Research__A.21.aspx","DOI":"10.1097\/ACM.0000000000000388"},{"key":"705_CR39","unstructured":"O'Connor EA, Whitlock EP, Gaynes B, Beil TL (2009) U.S. preventive services task force evidence syntheses, formerly systematic evidence reviews. In Screening for depression in adults and older adults in primary care: an updated systematic review. Agency for Healthcare Research and Quality (US)"},{"key":"705_CR40","unstructured":"Ontario Health (2021) Multi-gene pharmacogenomic testing that includes decision-support tools to guide medication selection for major depression: a health technology assessment (Ontario Technology Assessment Series, Issue. https:\/\/www.hqontario.ca\/evidence-to-improve-care\/health-technology-assessment\/reviews-and-recommendations\/multi-gene-pharmacogenomic-testing-that-includes-decision-support-tools-to-guide-medication-selection-for-major-depression. Accessed Jan 2024"},{"key":"705_CR41","unstructured":"Ontario Health (2023) Health technology assessments methods and process guide. https:\/\/www.hqontario.ca\/Portals\/0\/documents\/evidence\/reports\/hta-methods-and-process-guide-en.pdf. Accessed Jan 2024"},{"key":"705_CR42","doi-asserted-by":"publisher","unstructured":"Oslin DW, Lynch KG, Shih M-C, Ingram EP, Wray LO, Chapman SR, ... Group PCR (2022) Effect of pharmacogenomic testing for drug-gene interactions on medication selection and remission of symptoms in major depressive disorder: The PRIME Care Randomized Clinical Trial. JAMA 328(2): 151-161https:\/\/doi.org\/10.1001\/jama.2022.9805","DOI":"10.1001\/jama.2022.9805"},{"key":"705_CR43","doi-asserted-by":"publisher","unstructured":"Papastergiou J, Quilty LC, Li W, Thiruchselvam T, Jain E, Gove P, ... Pojskic N (2020) Pharmacogenomics guided versus standard antidepressant treatment in a community pharmacy setting: A randomized controlled trial. Clin Transl Sci 14(4): 1359\u20131368. https:\/\/doi.org\/10.1111\/cts.12986","DOI":"10.1111\/cts.12986"},{"key":"705_CR44","unstructured":"PharmGKB (2022) PharmGKB. https:\/\/www.pharmgkb.org\/. Accessed Jan 2024"},{"key":"705_CR45","unstructured":"QRS International (2022) NVivo. https:\/\/www.qsrinternational.com\/nvivo-qualitative-data-analysis-software\/home"},{"key":"705_CR46","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fgene.2020.00010","volume":"11","author":"T Rigter","year":"2020","unstructured":"Rigter T, Jansen ME, de Groot JM, Janssen SWJ, Rodenburg W, Cornel MC (2020) Implementation of pharmacogenetics in primary care: A multi-stakeholder perspective. Front Genet 11:10. https:\/\/doi.org\/10.3389\/fgene.2020.00010","journal-title":"Front Genet"},{"key":"705_CR47","unstructured":"Rogers EM (2003) Diffusion of Innovations, 5th Edition. Free Press. https:\/\/books.google.ca\/books?id=9U1K5LjUOwEC"},{"key":"705_CR48","doi-asserted-by":"publisher","unstructured":"Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, ... Fava M (2006) Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. American Journal of Psychiatry 163(11): 1905\u20131917. https:\/\/doi.org\/10.1176\/ajp.2006.163.11.1905","DOI":"10.1176\/ajp.2006.163.11.1905"},{"issue":"4","key":"705_CR49","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1002\/1098-240x(200008)23:4<334::aid-nur9>3.0.co;2-g","volume":"23","author":"M Sandelowski","year":"2000","unstructured":"Sandelowski M (2000) Whatever happened to qualitative description? Res Nurs Health 23(4):334\u2013340. https:\/\/doi.org\/10.1002\/1098-240x(200008)23:4%3c334::aid-nur9%3e3.0.co;2-g","journal-title":"Res Nurs Health"},{"issue":"12","key":"705_CR50","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.2105\/ajph.2013.301596","volume":"103","author":"JL Shaw","year":"2013","unstructured":"Shaw JL, Robinson R, Starks H, Burke W, Dillard DA (2013) Risk, reward, and the double-edged sword: perspectives on pharmacogenetic research and clinical testing among Alaska Native people. Am J Public Health 103(12):2220\u20132225. https:\/\/doi.org\/10.2105\/ajph.2013.301596","journal-title":"Am J Public Health"},{"key":"705_CR51","doi-asserted-by":"publisher","unstructured":"Slomp C, Morris E, Edwards L, Hoens AM, Landry G, Riches L, ... Austin J (2022) Pharmacogenomic testing for major depression: A qualitative study of the perceptions of people with lived experience and professional stakeholders. Can J Psychiatry. https:\/\/doi.org\/10.1177\/07067437221140383","DOI":"10.1177\/07067437221140383"},{"key":"705_CR52","doi-asserted-by":"publisher","unstructured":"Statistics Canada (2021a) Table 98\u201310\u20130020\u201301: age (in single years), average age and median age and gender: Canada, provinces and territories, census metropolitan areas and census agglomerations with parts.\u00a0https:\/\/doi.org\/10.25318\/9810002001-eng. Accessed Jan 2024","DOI":"10.25318\/9810002001-eng"},{"key":"705_CR53","doi-asserted-by":"publisher","unstructured":"Statistics Canada (2021b) Table 98\u201310\u20130351\u201301: visible minority by gender and age: Canada, provinces and territories.\u00a0https:\/\/doi.org\/10.25318\/9810035101-eng. Accessed Jan 2024","DOI":"10.25318\/9810035101-eng"},{"key":"705_CR54","doi-asserted-by":"publisher","unstructured":"Statistics Canada (2021c) Table 98\u201310\u20130481\u201301: place of work status by highest level of education and gender: Canada, provinces and territories, census divisions and census subdivisions. https:\/\/doi.org\/10.25318\/9810048101-eng. Accessed Jan 2024","DOI":"10.25318\/9810048101-eng"},{"issue":"6","key":"705_CR55","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1111\/cts.13083","volume":"14","author":"M Subasri","year":"2021","unstructured":"Subasri M, Barrett D, Sibalija J, Bitacola L, Kim RB (2021) Pharmacogenomic-based personalized medicine: Multistakeholder perspectives on implementational drivers and barriers in the Canadian healthcare system. Clin Transl Sci 14(6):2231\u20132241. https:\/\/doi.org\/10.1111\/cts.13083","journal-title":"Clin Transl Sci"},{"key":"705_CR56","doi-asserted-by":"publisher","unstructured":"Swen JJ, van der Wouden CH, Manson LE, Abdullah-Koolmees H, Blagec K, Blagus T, ... Guchelaar HJ (2023) A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study. Lancet 401(10374): 347\u2013356. https:\/\/doi.org\/10.1016\/s0140-6736(22)01841-4","DOI":"10.1016\/s0140-6736(22)01841-4"},{"issue":"3","key":"705_CR57","doi-asserted-by":"publisher","first-page":"21","DOI":"10.7812\/tpp\/15-046","volume":"19","author":"SB Trinidad","year":"2015","unstructured":"Trinidad SB, Coffin TB, Fullerton SM, Ralston J, Jarvik GP, Larson EB (2015) \u201cGetting off the Bus Closer to Your Destination\u201d: Patients\u2019 views about pharmacogenetic testing. Perm J 19(3):21\u201327. https:\/\/doi.org\/10.7812\/tpp\/15-046","journal-title":"Perm J"},{"issue":"6","key":"705_CR58","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/S1701-2163(15)30568-5","volume":"36","author":"M Vanstone","year":"2014","unstructured":"Vanstone M, King C, de Vrijer B, Nisker J (2014) Non-invasive prenatal testing: ethics and policy considerations. J Obstet Gynaecol Can 36(6):515\u2013526. https:\/\/doi.org\/10.1016\/S1701-2163(15)30568-5","journal-title":"J Obstet Gynaecol Can"},{"issue":"8","key":"705_CR59","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1177\/1049732315589745","volume":"25","author":"M Vanstone","year":"2015","unstructured":"Vanstone M, Yacoub K, Giacomini M, Hulan D, McDonald S (2015) Women\u2019s experiences of publicly funded non-invasive prenatal testing in Ontario, Canada: Considerations for health technology policy-making. Qual Health Res 25(8):1069\u20131084. https:\/\/doi.org\/10.1177\/1049732315589745","journal-title":"Qual Health Res"},{"issue":"5","key":"705_CR60","first-page":"1","volume":"19","author":"M Vanstone","year":"2019","unstructured":"Vanstone M, Cernat A, Majid U, Trivedi F, De Freitas C (2019) Perspectives of pregnant people and clinicians on noninvasive prenatal testing: A systematic review and qualitative meta-synthesis. Ont Health Technol Assess Ser 19(5):1\u201338","journal-title":"Ont Health Technol Assess Ser"}],"container-title":["Journal of Community Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12687-024-00705-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12687-024-00705-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12687-024-00705-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T15:26:25Z","timestamp":1719847585000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12687-024-00705-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,8]]},"references-count":60,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["705"],"URL":"https:\/\/doi.org\/10.1007\/s12687-024-00705-y","relation":{},"ISSN":["1868-6001"],"issn-type":[{"value":"1868-6001","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,8]]},"assertion":[{"value":"20 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received ethical approval from the Hamilton Integrated Research Ethics Board (HiREB) at McMaster University (#15351); informed consent was documented for all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}